** Shares of Austco Healthcare AHC.AX rise as much as 17.9% to A$0.395, their highest level since November 10, 2024
** The healthcare communication firm sees FY25 EBITDA between A$12.5 million ($8.19 million) and A$13.5 million, compared with A$8.1 million reported a year ago
** Also sees higher FY25 revenue of A$80 million - A$82 million
** Co says performance driven by strategic acquisitions
** YTD, shares up 41.8%
($1 = 1.5263 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。